Copyright
©The Author(s) 2025.
World J Gastroenterol. Aug 7, 2025; 31(29): 104830
Published online Aug 7, 2025. doi: 10.3748/wjg.v31.i29.104830
Published online Aug 7, 2025. doi: 10.3748/wjg.v31.i29.104830
Table 1 Characterization and clinical-pathological assessment of participants of study
Gender | n (%) |
Male | 14 (48.1) |
Female | 13 (51.9) |
Age of polyposis diagnosis | Mean (minimum-maximum) |
51 (19-69) | |
Polyposis type | |
Classic polyposis | 2 (7.4) |
Attenuated polyposis | 25 (92.6) |
Age of first diagnosed tumor | Mean (minimum-maximum) |
51 (19-64) | |
Primary diagnosed tumor site1 | |
Colorectal | 13 (76.4) |
Endometrium | 1 (5.9) |
Breast | 1 (5.9) |
Prostate | 1 (5.9) |
Thyroid | 1 (5.9) |
Age of second diagnosed tumor | Mean (minimum-maximum) |
59 (49-69) | |
Second primary diagnosed tumor site | |
Colorectal | 2 (11.8) |
Breast | 1 (5.9) |
Thyroid | 1 (5.9) |
Status | |
Alive, in follow-up | 26 (96.3) |
Deceased | 1 (3.7) |
Table 2 Pathogenic and likely pathogenic variants identified in the participants of study
Index case | Polyposis/tumor (age at diagnosis) | Gene | Transcript | cDNA change | Protein change | Revel | GnomAD AF | Classification1 |
1165 | Attenuated polyposis (53)/CRC (52) | PCSK7 | NM_004716.3 | c.1054+1del | - | NP | NR | P |
1488 | Attenuated polyposis (40)/endometrium hyperplasia (50) | DKK4 | NM_014420.3 | c.108del | p.(Lys37Argfs50) | NP | NR | LP |
NTHL1 | NM_002528.7 | c.244C>T | p.(Gln82) | NP | 1.40e-03 | P | ||
PIDD1 | NM_145886.3 | c.2042-2A>G | - | NP | 8.41e-05 | LP | ||
1490 | Attenuated polyposis (52) | ST7 L | NM_017744.5 | c.540dup | p.(Tyr181Ilefs3) | NP | NR | LP |
1536 | Breast (58)/attenuated polyposis (63) | CD44 | NM_001001392.2 | c.250C>T | p.(Gln84) | NP | NR | LP |
TG | NM_003235.5 | c.4588C>T | p.(Arg1530) | 0.329 | 8.354e-05 | LP | ||
1831 | Attenuated polyposis (36) | HLTF | NM_003071.3 | c.1160+2T>C | - | NP | 3.98E-06 | P |
MUC16 | NM_024690.2 | c.14516del | p.(Gly4839Valfs55) | NP | 8.032e-06 | LP | ||
2325 | Attenuated polyposis (59)/CRC (59) | OBSCN | NM_001271223.2 | c.3574C>T | p.(Gln119) | NP | NR | LP |
2448 | Attenuated polyposis (19)/CRC (19) | PMS2 | NM_000535.7 | c.1882C>T | p.(Arg628) | NP | 1.59E-05 | P |
278 | Attenuated polyposis (55)/CRC (55) | MUC16 | NM_024690.2 | c.14338_14341del | p.(Thr4780 Leufs4) | NP | 1.21E-05 | LP |
TINF2 | NM_001099274.3 | c.1202dup | p.(Asn401 Lysfs19) | NP | NR | LP | ||
454 | Classic polyposis (19) | FRK | NM_002031.3 | c.190C>T | p.(Arg64) | NP | 1.591e-05 | LP |
517 | Attenuated polyposis (56) | PNKP | NM_007254.4 | c.1541_1548dup | p.(Gln517Cysfs) | NP | NR | P |
547 | Attenuated polyposis (51)/CRC (51) | A1CF | NM_014576.4 | c.826C>T | p.(Arg276) | NP | 7.982e-06 | LP |
907 | Attenuated polyposis (61) | AHRR | NM_001377236.1 | c.938C>A | p.(Ser313) | NP | NR | LP |
- Citation: dos Santos W, Pereira AS, Laureano T, de Andrade ES, Reis MT, Garcia FA, Campacci N, Melendez ME, Reis RM, Galvão HC, Palmero EI. Whole-exome sequencing identifies new pathogenic germline variants in patients with colorectal polyposis. World J Gastroenterol 2025; 31(29): 104830
- URL: https://www.wjgnet.com/1007-9327/full/v31/i29/104830.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i29.104830